David
Garcia Azorin
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (10)
2024
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
European Journal of Neurology, Vol. 31, Núm. 5
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
2022
-
Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study
European Journal of Neurology, Vol. 29, Núm. 10, pp. 3102-3111
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry
Journal of the Neurological Sciences, Vol. 423
2019
-
Neurocooperación: Un nuevo horizonte de la neurología
Kranion, Vol. 14, Núm. 3, pp. 114-119
-
Neurología y cooperación: ¿Utopía o realidad? Experiencia de un proyecto pionero de neurocooperación en África
Kranion, Vol. 14, Núm. 2, pp. 67-72